Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Yasuhiro Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9046-5466. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1620/tjem.2023.j109↗
  2. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14041↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasufumi Sato · 2 shared papers, 2019–2024 · strength 0.56
  2. Shin Hamada · 1 shared paper, 2019 · strength 0.11
  3. Rie Iida‐Norita · 1 shared paper, 2019 · strength 0.11
  4. Atsushi Masamune · 1 shared paper, 2019 · strength 0.11
  5. Toru Furukawa · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.